Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Truist analyst Matthew Coad raised the price target on Fiserv to $53 from $52 and maintained a ‘Hold’ rating on the shares.

The company announced integrations with three education payment platforms in the U.S., allowing students to pay tuition and fees directly through its platform or via Venmo.

Contract renewals could lift margins, Truist says.

Lowe's (LOW) underperformance versus Home Depot (HD) may be at least partly attributable to its heav

Truist just raised its CrowdStrike price target by a wide margin and called the cybersecurity setup constructive, yet the stock is bleeding into earnings week anyway. Two smaller names are quietly bucking the selloff, and where the money is hiding tells you something important about where budgets are actually going.

Truist raised its price targets for CrowdStrike, Rubrik and SailPoint while maintaining ‘Buy’ ratings on all three stocks.

Does JPM's scale, earnings resilience and rising capital returns outweigh TFC's cheaper valuation and higher dividend yield? Let's find out.

Telsey, Truist, and Deutsche Bank raised Target’s price targets ahead of fiscal second-quarter 2026 earnings.

Since February 2026, Truist Financial has been in a holding pattern, posting a small return of 0.9% while floating around $52.67. The stock also fell short of the S&P 500’s 13.1% gain during that period.

Wall Street sees booming cloud growth as a sign that AI spending is giving a return on investment.

Oddity Tech’s modeled fair value has shifted from US$10.25 to about US$11.07, signaling a modest recalibration in where some analysts see the stock’s long term anchor. That move comes alongside more cautious Street commentary after the Q1 update, with firms weighing higher perceived execution risk against early signs of relief in customer acquisition costs and spending data. Read on to see what is driving the changing narrative around Oddity Tech and how you can keep track of the next set of...

Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. Still, investors are uneasy as banks face challenges from credit quality concerns and potential regulatory changes. These doubts have certainly contributed to banking stocks’ recent underperformance - over the past six months, the industry’s 8% gain has fallen behind the S&P 500’s 13% rise.

Investing.com -- Truist stated in a note Friday that a reported takeover approach for Workday could revive a dormant software dealmaking cycle, and has refreshed its lists of potential takeout candidates across its coverage.

Amer Sports (AS) is positioned well to outperform despite a tough operating environment amid its uni

Cisco Systems gains Wall Street confidence as Truist, UBS and Rosenblatt raise price targets, citing strong results, AI demand, and networking growth.

Revenue estimates rise while near-term EBITDA falls

Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) fell 2.8% in the afternoon session after a significant price target cut from an analyst overshadowed the company's strong quarterly earnings report.

The recent announcement by The Clearing House regarding a shared tokenized deposit network is less about technological innovation and more about a defensive maneuver to protect the $6.6 trillion in deposits currently at risk from stablecoin encroachment. While individual banks have been busy launching proprietary pilots, the real story is the consortium’s attempt to build […]

The latest analyst update on AbCellera Biologics reflects a higher Fair Value estimate of US$14.63 compared with the prior figure of US$10.43. This shift aligns with more constructive Street research that follows recent clinical data and new partnership agreements. These developments have prompted several firms to revisit their rating and price target work on the stock. Read on to see how these changing assumptions fit into the broader narrative and how you can track the story from...

Truist recommends buying Best Buy stock heading into its Q2 earnings on Aug. 27. Here’s why the investment firm is bullish on BBY shares.

Consumer stocks were lower late Tuesday afternoon, with the State Street Consumer Staples Select Sec

Best Buy (BBY) is seeing improving sales momentum amid factors such as continued replacement demand

The recent announcement by The Clearing House regarding a shared tokenized deposit network is less about technological innovation and more about a defensive maneuver to protect the $6.6 trillion in deposits currently at risk from stablecoin encroachment. While individual banks have been busy launching proprietary pilots, the real story is the consortium’s attempt to build […]

Deckers Outdoor has seen its fair value estimate move from about US$126.86 to about US$122.81, pointing to a slightly lower implied price target in recent model updates. That shift lines up with research where some analysts trim targets while still emphasizing the strength of Deckers Outdoor's brands and direct to consumer performance. As you read on, you will see how to interpret this evolving narrative and what it may mean for your own view of the stock. Stay updated as the Fair Value for...

MasTec sits at the center of an active reassessment of price targets, with updated modeling work lifting fair value from about $349 to about $427. Behind that shift, analysts are weighing fresh guidance, the acquisition of The Superior Group, and a mix of bullish and more cautious views on how execution and segment pressure could affect valuation over time. As you read on, you will see how these moving targets and narratives fit together and how to keep track of the story as it...

Shopify sits at the center of a wide valuation debate, with recent analyst price targets clustering between US$130 and US$192. Many of the higher targets in the US$175 to US$192 range lean on broad execution and rising AI usage, while more cautious calls around US$130 to US$150 point to competition and a mixed software spending backdrop. As you read on, you will see how to track these shifting targets and what they may signal about the evolving narrative around Shopify. Analyst Price Targets...

A brutal earnings miss sent one ad-tech giant into freefall while its closest rivals barely flinched, raising urgent questions about whether the company faces a temporary stumble or a much deeper structural breakdown.

Sylvamo’s fair value estimate has been adjusted from US$59.00 to US$51.75, which narrows the gap with recent Street price targets clustered in the mid to high US$40s. This change reflects a more balanced analyst stance, as bullish and bearish views converge around a tighter price target range. As you read on, you will see how these updated targets fit into the evolving Sylvamo story and what to watch next in the analyst narrative. Stay updated as the Fair Value for Sylvamo shifts by adding it...

The latest update to the Assurant analyst narrative includes a small lift in the modelled fair value, from US$293 to about US$300.50, which many investors will see as a modest reset of the price target range. That move sits alongside recent bullish commentary that highlights what analysts view as solid execution in property and casualty insurance and ongoing contribution from Connected Living. Read on to see how this evolving narrative might shape the way you track Assurant from here. Stay...

The fair value estimate for CVS Health has shifted from US$111.92 to US$114.88, signaling a modest reset in where analysts think the stock could be worth over time. This change lines up with recent research that leans constructive on CVS Health ahead of upcoming earnings, while still calling out execution and policy risks that could affect how closely the stock trades to that mark. As you read on, you will see how to track this evolving story and what to watch as the narrative around CVS...

Jefferies and Truist raised their price targets despite a 7% post-earnings decline.

Wall Street firms have raised their price targets on Shopify following its fiscal second-quarter earnings.

Analysts raised price targets after earnings, while bullish retail traders said AMD could climb as high as $800 on AI-driven growth.

The updated analyst framework for Fulcrum Therapeutics lifts the Fair Value estimate from US$5.43 to US$5.83 per share. This shift in price target sits against a backdrop of sharply changed Street commentary after the decision to discontinue pociredir, with more focus on cash, restructuring and the ongoing review of options than on late stage development potential. Read on to see how this evolving narrative could matter for your own view on Fulcrum Therapeutics and how to track the next set...

The updated analyst model for Integer Holdings now points to a fair value of US$112.14, up from US$97.56, which reflects a roughly 15% uplift in the price target. Much of this shift ties back to fresh Street commentary following KKR’s agreed all cash offer of US$127 per share, with analysts reframing views around the stock through the lens of deal terms and closing risk. As you read on, you will see how this new price target fits into the evolving narrative around Integer Holdings and what it...

ON Semiconductor (ON) is seeing a cyclical recovery alongside growing AI and data center demand, tho

Investing.com -- Truist Securities downgraded Intuit to Hold from Buy on Monday and lowered its price target to $350 from $410, flagging a softening growth outlook and a lack of near-term catalysts for the stock.

Barclays said Snap's return to nearly 20% revenue growth should help rebuild investor confidence and lifted its price target to $16.

MarineMax sits at the center of a fresh price target debate after updated valuation work lifted an estimated fair value per share from US$35.29 to US$37.86. The move comes as analysts weigh a higher US$39 target from bullish voices against a more cautious US$35 stance from others who are focused on recent deal speculation and earnings trends. As you read on, you will see how these differing views are shaping the evolving MarineMax story and what signals to watch next. Analyst Price Targets...

Barclays said Snap's return to nearly 20% revenue growth should help rebuild investor confidence and lifted its price target to $16.

FEATURE Stocks rallied Monday with new records in reach for the and after President Donald Trump said he would restart talks with Iran, bolstering investors’ hopes of a cease-fire in the Middle East.

Shares of Corning had a tough July but a Truist analyst team believes the stock now has a “more reasonable entry point.” Shares of the optical networking company declined 0.5% to $137.52 in premarket trading on Monday after ending Friday up 2.2%. Corning and other optical networking names have become a major part of the artificial-intelligence trade.

Corning’s shares ended in the red in 16 out of 22 trading sessions in July, with the stock plummeting in double-digits on three of those days.

Camden Property Trust now sits against a refreshed fair value estimate that has edged from US$113.94 to US$116.33, which gives you an updated anchor point for thinking about price targets. The mixed set of analyst views, ranging from Buy to Underperform and stretching up to price targets near US$125, shows that Wall Street is actively reassessing risk, growth and execution around Camden Property Trust rather than moving in lockstep. Read on to see how these shifting targets and narratives fit...

The latest update on Diversified Energy trims the Fair Value price target from £16.25 to £14.86, which represents about a 9% cut to the central valuation mark. Analysts link this reset to a more cautious stance that incorporates current assumptions on natural gas pricing, revenue trends, and company margins ahead of Q2 results. As you read on, you will see how these shifting targets shape the evolving narrative around Diversified Energy and what to watch next. Stay updated as the Fair Value...

Trex Company now carries a revised fair value estimate of about $52.94, up from $48.50, as the latest model update filters through to price targets. Many analysts are lifting their targets after Trex Company issued updated guidance, preliminary Q2 figures and outlined changes to its distribution approach, although views on the stock remain split. As you read on, you will see how these shifting targets fit into the broader narrative and what to watch as the story continues to evolve. Stay...

Truist Financial has rallied the broader market over the past year, yet analysts remain skeptical about the stock’s prospects.

DaVita’s modeled fair value has shifted from US$193.71 to US$208.57, signaling a fresh round of updated price targets that investors are watching closely. Recent analyst commentary has taken a mixed but generally constructive tone, with higher targets often linked to DaVita’s growth investments, technology efforts, and focus on patient outcomes. As you read on, you will see how these changing targets fit into the broader DaVita story and what to monitor as the narrative evolves. Analyst Price...

Truist Financial (TFC) is back in focus after the board declared regular cash dividends on both its common and multiple preferred stock series, with ex-dividend dates scheduled for mid August and payments set for early September. See our latest analysis for Truist Financial. Truist Financial's recent dividend decisions come after a period of steady gains, with a 30 day share price return of 4.95% and a year to date share price return of 6.53%. The 1 year total shareholder return of 23.83% and...